IL129430A0 - Substituted arylalkylamines as neurokinin antagonists - Google Patents

Substituted arylalkylamines as neurokinin antagonists

Info

Publication number
IL129430A0
IL129430A0 IL12943096A IL12943096A IL129430A0 IL 129430 A0 IL129430 A0 IL 129430A0 IL 12943096 A IL12943096 A IL 12943096A IL 12943096 A IL12943096 A IL 12943096A IL 129430 A0 IL129430 A0 IL 129430A0
Authority
IL
Israel
Prior art keywords
alkyl
heteroaryl
nr6r7
aryl
phenyl
Prior art date
Application number
IL12943096A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL129430A0 publication Critical patent/IL129430A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
IL12943096A 1996-10-28 1996-10-28 Substituted arylalkylamines as neurokinin antagonists IL129430A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/016822 WO1998018761A1 (en) 1996-10-28 1996-10-28 Substituted arylalkylamines as neurokinin antagonists

Publications (1)

Publication Number Publication Date
IL129430A0 true IL129430A0 (en) 2000-02-17

Family

ID=22255993

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12943096A IL129430A0 (en) 1996-10-28 1996-10-28 Substituted arylalkylamines as neurokinin antagonists

Country Status (12)

Country Link
EP (1) EP0934271B1 (de)
JP (1) JP2001507673A (de)
KR (1) KR20000052856A (de)
AT (1) ATE248818T1 (de)
AU (1) AU7460796A (de)
CA (1) CA2268866C (de)
DE (1) DE69629846T2 (de)
ES (1) ES2202481T3 (de)
HU (1) HUP9903653A3 (de)
IL (1) IL129430A0 (de)
NZ (1) NZ334966A (de)
WO (1) WO1998018761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
TW200303304A (en) 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
US6919356B2 (en) 2002-09-26 2005-07-19 Bristol Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
CA2507509A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
TW200524868A (en) 2003-07-31 2005-08-01 Zeria Pharm Co Ltd Benzylamine derivatives
SE0400208D0 (sv) 2004-02-02 2004-02-02 Astrazeneca Ab Chemical compounds
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
EP0702681A1 (de) * 1993-06-07 1996-03-27 Merck & Co. Inc. Spiro-substituierte azaringe als neurokinin antagonisten

Also Published As

Publication number Publication date
HUP9903653A3 (en) 2001-05-28
HUP9903653A2 (hu) 2000-03-28
DE69629846T2 (de) 2004-07-08
CA2268866A1 (en) 1998-05-07
WO1998018761A1 (en) 1998-05-07
EP0934271B1 (de) 2003-09-03
CA2268866C (en) 2005-12-06
EP0934271A1 (de) 1999-08-11
NZ334966A (en) 2000-10-27
JP2001507673A (ja) 2001-06-12
ATE248818T1 (de) 2003-09-15
DE69629846D1 (de) 2003-10-09
ES2202481T3 (es) 2004-04-01
KR20000052856A (ko) 2000-08-25
AU7460796A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
NO302818B1 (no) Sulfonamidokarboksamider, anvendelse derav for fremstilling av farmasöytiske preparater og mellomprodukter for fremstilling av förstnevnte
ZA947086B (en) Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
DE69002248T2 (de) 1,2-Cyclohexylaminoarylamide zu Verwendung als Analgetika.
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
FI102966B (fi) Menetelmä terapeuttisesti käyttökelpoisten guanidiinien valmistamiseks i
FI980175A (fi) 2-sulfonamidofenonijohdannaisia
IL129430A0 (en) Substituted arylalkylamines as neurokinin antagonists
HUP9902091A2 (hu) Benzodioxán-metil-amin indol-alkil-származékok és alkalmazásuk 5-HT1A receptor ligandumként
DE69413393D1 (de) In 15-stellung substituierte 4-azasteroide
YU71496A (en) Azetidines, their salts, application and process for preparation
NO953052L (no) Nye pyrrolokarbazoler
DE59307841D1 (de) Sulfoalkylgruppenhaltige Alkylhydroxyalkylcelluloseether
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
MY131762A (en) Pharmaceutical compounds
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
EA200201197A1 (ru) Способ экструзии непрерывной формовки
DE69505756D1 (de) Verfahren zur Herstellung von (-)-N-methyl-N-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-benzamid und ihr pharmazeutisch annehmbares Salz
CA2245926A1 (en) 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
FR2712584B3 (fr) Procédé d'obtention d'un ciment géopolymère et produits obtenus par ce procédé.
CO4340626A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
DK0539330T3 (da) Fremgangsmåde til fremstilling af substituerede indoler
FR2712882B3 (fr) Procédé d'obtention d'un ciment Géopolymère par activation calcique, et produits obtenus par ce procédé.
HUP0004061A2 (hu) Eljárás piperidinil-amino-metil-trifluor-metil ciklusos étervegyületek előállítására és intermedierjeik
ATE188470T1 (de) Chinolondisulfide als zwischenverbindungen
CA2187816A1 (fr) Nouveaux derives alkyl-3-oxo-alcanoates et leur procede de preparation